Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single centerYucai Wang, Wei Ding, Marcella Tschautscher et al.|Haematologica|2019Cited by 134
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practicePaul J. Hampel, Sameer A. Parikh, Wei Ding et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 63
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J. Archibald, Sameer A. Parikh, Asher Chanan‐Khan et al.|Annals of Hematology|2020Cited by 56
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practiceSameer A. Parikh, Tait D. Shanafelt, Sara J. Achenbach et al.|Cancer Medicine|2020Cited by 55
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLLSameer A. Parikh, Tait D. Shanafelt, Kari G. Rabe et al.|Blood|2021Cited by 52